eLifeMolecular BiologyPeer-reviewed journal article
Membrane Bound O-Acyltransferase 7 (MBOAT7) Shapes Lysosomal Lipid Homeostasis and Function to Control Alcohol-Associated Liver Injury
Venkateshwari VaradharajaniD, Iyappan RamachandiraniD, William J. MasseyiD, Raghav JainiD, Rakhee BanerjeeiD, Anthony J. HorakiD, Megan R. McMulleniD, Emily HuangiD, Annette BellariD, Shuhui Wang LorkowskiiD, Kailash GulshaniD, Robert Nathaniel HelsleyiD, Isabella JamesiD, Vai PathakiD, Jaividhya Dasarathy, Nicole WelchiD, Srinivasan DasarathyiD, David W. StreemiD, Ofer ReizesiD, Daniela S. AllendeiD, Jonathan D. SmithiD, Judith SimcoxiD, Laura E. NagyiD, Jonathan Mark BrowniD
Abstract
Several recent genome-wide association studies (GWAS) have identified single nucleotide polymorphism (SNPs) near the gene encoding membrane-bound O-acyltransferase 7 (MBOAT7) that is associated with advanced liver diseases. In fact, a common MBOAT7 variant (rs641738), which is associated with reduced MBOAT7 expression, confers increased susceptibility to non-alcoholic fatty liver disease (NAFLD), alcohol-associated liver disease (ALD), and liver fibrosis in those chronically infected with hepatitis viruses B and C. The MBOAT7 gene encodes a lysophosphatidylinositol (LPI) acyltransferase enzyme that produces the most abundant form of phosphatidylinositol 38:4 (PI 18:0/20:4). Although these recent genetic studies clearly implicate MBOAT7 function in liver disease progression, the mechanism(s) by which MBOAT7-driven LPI acylation regulates liver disease is currently unknown. Previously we showed that antisense oligonucleotide (ASO)-mediated knockdown of Mboat7 promoted non-alcoholic fatty liver disease (NAFLD) in mice (Helsley et al., 2019). Here, we provide mechanistic insights into how MBOAT7 loss of function promotes alcohol-associated liver disease (ALD). In agreement with GWAS studies, we find that circulating levels of metabolic product of MBOAT7 (PI 38:4) are significantly reduced in heavy drinkers compared to age-matched healthy controls. Hepatocyte specific genetic deletion (Mboat7HSKO), but not myeloid-specific deletion (Mboat7MSKO), of Mboat7 in mice results in enhanced ethanol-induced hepatic steatosis and high concentrations of plasma alanine aminotransferase (ALT). Given MBOAT7 is a lipid metabolic enzyme, we performed comprehensive lipidomic profiling of the liver and identified a striking reorganization of the hepatic lipidome upon ethanol feeding in Mboat7HSKO mice. Specifically, we observed large increases in the levels of endosomal/lysosomal lipids including bis(monoacylglycero)phosphates (BMP) and phosphatidylglycerols (PGs) in ethanol-exposed Mboat7HSKO mice. In parallel, ethanol-fed Mboat7HSKO mice exhibited marked dysregulation of autophagic flux and lysosomal biogenesis when exposed to ethanol. This was associated with impaired transcription factor EB (TFEB)-mediated lysosomal biogenesis and accumulation of autophagosomes. Collectively, this works provides new molecular insights into how genetic variation in MBOAT7 impacts ALD progression in humans and mice. This work is the first to causally link MBOAT7 loss of function in hepatocytes, but not myeloid cells, to ethanol-induced liver injury via dysregulation of lysosomal biogenesis and autophagic flux.
- Citations
- 9
- FWCI
- 1.78
- Field percentile
- top 15%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Membrane-Bound O-Acyltransferase 7 (MBOAT7)-Driven Lysophosphatidylinositol (LPI) Acylation in Adipocytes Contributes to Systemic Glucose Homeostasis
W. Massey, V. Varadharajan, … J. M. Brown·bioRxiv·May 19, 2022
- Enhancing Hepatic MBOAT7 Expression Does Not Improve Nonalcoholic Steatohepatitis in Mice
M. C. Sharpe, K. D. Pyles, … K. S. McCommis·bioRxiv·Mar 24, 2022
- TM6SF2/PNPLA3/MBOAT7 loss-of-function genetic variants impact on NAFLD development and progression both in patients and in in vitro models
M. Longo, M. Meroni, … Paola Dongiovanni·Digestive and Liver DiseasePeer-reviewed·Feb 23, 2021
- A partner switch from CDS2 to RAB1A redirects MBOAT7 to inhibit DGAT2-mediated lipid droplet growth
Jiesi Xu, Jianxin Zhang, … Xun Huang·bioRxiv·Aug 26, 2025
- Downregulation of CYP7B1 caused by lipotoxicity associates with the progression of non-alcoholic steatohepatitis
Y. Watanabe, K. Kinoshita, … R. Sato·bioRxiv·May 10, 2023
- Deciphering the genetic links between NAFLD and co-occurring conditions using a liver gene regulatory network
Sreemol Gokuladhas, William S. Schierding, … Justin Martin O'Sullivan·bioRxiv·Dec 8, 2021